37 results on '"Vogelmeier, Claus F."'
Search Results
2. Potential systemic effects of acquired CFTR dysfunction in COPD
3. COPD and multimorbidity: recognising and addressing a syndemic occurrence
4. Diagnostic Performance of a Machine Learning Algorithm (Asthma/Chronic Obstructive Pulmonary Disease [COPD] Differentiation Classification) Tool Versus Primary Care Physicians and Pulmonologists in Asthma, COPD, and Asthma/COPD Overlap
5. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
6. Association of coronary artery calcification with clinical and physiological characteristics in patients with COPD: Results from COSYCONET
7. A scoping review of mHealth monitoring of pediatric bronchial asthma before and during COVID-19 pandemic
8. Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD
9. Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications: Results From the COPD and Systemic Consequences-Comorbidities Network
10. COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort
11. Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis
12. Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease
13. COPDCompEx: A novel composite endpoint for COPD exacerbations to enable faster clinical development
14. Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET
15. Utilization and determinants of use of non-pharmacological interventions in COPD: Results of the COSYCONET cohort
16. Goals of COPD treatment: Focus on symptoms and exacerbations
17. CAT score single item analysis in patients with COPD: Results from COSYCONET
18. Left ventricular volume and wall stress are linked to lung function impairment in COPD
19. Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling
20. The revised GOLD 2017 COPD categorization in relation to comorbidities
21. Prevalence of comorbidities in COPD patients by disease severity in a German population
22. GOLD 2017 treatment pathways in ‘real life’: An analysis of the DACCORD observational study
23. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
24. Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD
25. New concepts in asthma: clinical phenotypes and pathophysiological mechanisms
26. Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease
27. From Heart Failure to Highly Unsaturated Fatty Acid Deficiency and Vice Versa: Bidirectional Heart and Liver Interactions
28. Wall stress determines systolic and diastolic function — Characteristics of heart failure
29. EFFICACY AND SAFETY OF DUPILUMAB FOR COPD WITH TYPE 2 INFLAMMATION
30. Airflow limitation in COPD is associated with increased left ventricular wall stress in coincident heart failure
31. Tackling the global burden of lung disease through prevention and early diagnosis
32. Exacerbations of chronic obstructive pulmonary disease: time to rename
33. COPD & COVID-19
34. COPD & COVID-19
35. Fe de errores de “Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD” [Arch Bronconeumol. 2017;53:128–49]
36. Late Gadolinium Enhancement in Sarcoidosis: Ventricular Wall Stress Should Not Be Overlooked
37. Use of a Highly Purified α1-Antitrypsin Standard to Establish Ranges for the Common Normal and Deficient α1-Antitrypsin Phenotypes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.